Shares of medical-technology company UltraGreen.ai rose in their Singapore trading debut, following the city-state's largest nonproperty initial public offering this year.
The stock climbed as much as 12% to US$1.62 on Wednesday before paring gains to trade at US$1.56 by midday.
The Singapore-based company, which offers fluorescence imaging technology for surgeries, sold 112.1 million shares at US$1.45 each in its listing. The IPO drew strong interest and was 13.6 times subscribed, UltraGreen said Tuesday.
Including commitments from 16 cornerstone investors, such as insurer AIA Group's AIA Investment Management and Japan's Amova Asset Management, its gross proceeds totaled about US$400 million.
UltraGreen is also a portfolio company of investment company 65 Equity Partners, which is in turn backed by Singapore state investor Temasek. 65 Equity Partners increased its investment in UltraGreen through a cornerstone agreement, the company said.
The medtech company intends to use its IPO proceeds for its core products, including its data platform and fluorescence-imaging products, and for expansion across Asia-Pacific, Europe, the Middle East and Africa, it said.
Citigroup and DBS Bank were the joint bookrunners and underwriters for UltraGreen's listing.
Singapore has become Southeast Asia's largest IPO market by proceeds, with nine deals raising US$1.6 billion as of mid-November this year, according to professional services firm Deloitte. It is the city-state's best showing since 2019, thanks to listings by two major real-estate investment trusts.
Comments